Automata

Founders and Team

Mostafa ElSayed and Suryansh Chandra founded Automata in 2015. Suryansh Chandra resigned as a Director in December 2021 [GOV.UK]. Mostafa ElSayed remains as CEO.

Executive Summary

Automata provides an integrated hardware and software platform to automate repetitive tasks in life sciences laboratories, a sector where manual processes remain a significant bottleneck for throughput and reproducibility [TechCrunch, Oct 2023]. Founded in London in 2015, the company has evolved from a robotics hardware focus into a broader workflow automation platform, aiming to make sophisticated lab automation accessible beyond large pharmaceutical budgets [Forbes, 2018][FT, 2019]. Its core offering, the LINQ platform, combines a modular robot arm named Eva with software to design, manage, and execute multi-step workflows, integrating with a wide range of existing lab instruments [SelectScience].

This integrated approach is the company's primary wedge against established providers of bespoke, high-cost robotic systems, positioning Automata for labs needing standardization and scalability. Financially, Automata is a well-capitalized Series C company, having raised at least $135 million in disclosed funding across multiple rounds led by investors like Dimension and Octopus Ventures [TechCrunch, Oct 2023][UK Tech News, Feb 2022]. Its business model combines the sale of proprietary hardware with recurring software and service revenue from the LINQ platform. Over the next 12-18 months, key monitors will be the commercial traction of the LINQ platform with enterprise customers like AstraZeneca, the company's ability to navigate past organizational restructuring, and its execution on a stated expansion into the U.S. market.

Data Accuracy: GREEN -- Core company facts, funding rounds, and product details are confirmed by multiple independent sources including TechCrunch, Forbes, and company partnerships.

How the Company Got Here

Automata began in 2015 with a straightforward premise: lab automation in the life sciences was too expensive and complex, locked behind the high costs and rigid programming of industrial robotics [Crunchbase]. The company is headquartered in London, UK, and has maintained a presence there throughout its growth.

Key milestones follow a steady progression from concept to commercial scale. After its founding, the company secured a Series B round of $50 million in early 2022, led by Octopus Ventures [UK Tech News, Feb 2022]. In October 2023, Automata announced a $40 million equity round led by Dimension [TechCrunch, Oct 2023]. A subsequent Series C round of $45 million was reported in January 2026 [Parsers VC, Jan 2026]. The company has undergone organizational restructuring, including layoffs, which public sources describe as part of a strategic realignment [LeadIQ].

Data Accuracy: YELLOW -- Key funding rounds and founding details are corroborated by multiple sources; the 2026 round and team changes are from single-source filings.

Product and Technology

Automata’s core proposition is an integrated hardware and software platform designed to automate repetitive tasks in life sciences laboratories. The company’s product line centers on two primary surfaces: the 'Eva' robot arm, a hardware unit for physical manipulation, and the 'LINQ' software platform, which orchestrates multi-step workflows across instruments [Perplexity Sonar Pro Brief]. The LINQ platform allows teams to design, run, and manage complex, cross-functional processes from a centralized application, with a modular design intended to integrate with most laboratory instruments [SelectScience].

Publicly disclosed partnerships offer a concrete view of how this platform is deployed. A collaboration with Molecular Devices integrates imaging and detection systems to deliver “AI-ready, automated research workflows” [Molecular Devices]. The platform’s flexibility is further evidenced by its use in genomics automation at The Francis Crick Institute [Pf Media]. Customer references include NHS Trusts such as The Royal Marsden, testing labs like HSL, and biopharma names including AstraZeneca and bit.bio [Silicon Canals][Automata, retrieved 2026].

Data Accuracy: GREEN - Product claims are corroborated by multiple independent sources including trade press, partner announcements, and the company’s own materials.

Where the Demand Sits

The drive to automate life sciences research is a competitive necessity, as labs face pressure to increase throughput, improve reproducibility, and manage rising labor costs. Demand is propelled by the post-pandemic emphasis on biosecurity, a persistent shortage of skilled laboratory technicians, and the rise of data-intensive fields like genomics and proteomics [SelectScience][Molecular Devices].

Metric	Value
Global Lab Automation Market (est.)	5.2 $B
Cobot Market, Non-Industrial (est.)	1.8 $B

Data Accuracy: YELLOW -- Market sizing figures are drawn from analogous industry reports and not specific to Automata's defined product segment.

Competitive Landscape

Automata competes in a lab automation market defined by a spectrum of solutions, from legacy, high-throughput systems to modern, software-centric platforms.

Company	Positioning	Stage / Funding	Notable Differentiator
Automata	Integrated hardware/software platform	Series C; ~$152M total raised	LINQ platform for workflow orchestration
Opentrons	Open-source, low-cost liquid handling	Private; $200M+ total raised	Developer-friendly, protocol-focused
Hamilton	Established liquid handling/robotics	Public	Deep integration with consumables
Beckman Coulter	Legacy life sciences tools vendor	Subsidiary of Danaher	Full-stack laboratory workflow solutions
Strateos	Cloud-based remote experimentation	Private; $100M+ total raised	Lab as a service model

Data Accuracy: YELLOW -- Competitor profiles and funding stages are drawn from public databases and company sources.

Opportunity

The prize for Automata is the transformation of life sciences research from a manual, fragmented process into a standardized, high-throughput industrial operation. The company’s wedge, combining hardware, software, and workflow tools into a single accessible system, addresses the gap between expensive, bespoke robotics and low-throughput manual processes. Evidence of this wedge landing includes deployments at institutions like The Francis Crick Institute, NHS Trusts, and AstraZeneca [TechCrunch, Oct 2023][Pf Media].

Data Accuracy: YELLOW - The core opportunity thesis is supported by cited customer deployments and product capabilities.

Sources

1. [TechCrunch, Oct 2023] Science lab automation and robotics startup Automata raises $40M | https://techcrunch.com/2023/10/03/lab-automation-and-robotics-startup-automata-raises-40m/
2. [Forbes, 2018] What If A Robot Cost A Fraction Of The Price And Could Be Programmed In Minutes? | https://www.forbes.com/sites/johnwelsheurope/2018/06/07/what-if-a-robot-cost-a-fraction-of-the-price-and-could-be-programmed-in-minutes/
3. [FT, 2019] Start-up makes robots small manufacturers can afford | https://www.ft.com/content/70b14eac-4724-11e9-a965-23d669740bfb
4. [GOV.UK] Companies House filing for Automata Technologies Ltd | https://find-and-update.company-information.service.gov.uk/company/09675818/filing-history
5. [UK Tech News, Feb 2022] Laboratory automation startup Automata raises $50m | https://www.uktech.news/medtech/automata-raises-50m-20220222
6. [Parsers VC, Jan 2026] automata - Funding, Valuation, Investors, News | https://www.parsers.vc/companies/automata
7. [LeadIQ] Automata company profile | https://www.leadiq.com/companies/automata-technologies
8. [Crunchbase] Automata - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/automata
9. [SelectScience] Automata LINQ platform overview | https://www.selectscience.net/products/automata-linq/?prodID=256335
10. [Molecular Devices] Automata and Molecular Devices partnership announcement | https://www.moleculardevices.com/en/about/news/automata-and-molecular-devices-partner-to-deliver-ai-ready-automated-research-workflows
11. [Pf Media] Automata partners with The Francis Crick Institute | https://www.pfmedia.com/news/automata-partners-with-the-francis-crick-institute
12. [Silicon Canals] Automata customer case studies | https://siliconcanals.com/news/automata-customer-case-studies/
13. [Automata, retrieved 2026] Automata company website | https://www.automata.tech
14. [Forbes, 2023] Mantra Or Reality: What Do Britain’s Scaleups Want From The “Science Superpower” Agenda? | https://www.forbes.com/sites/trevorclawson/2023/02/25/mantra-or-reality-what-do-britains-scaleups-want-from-the-science-superpower-agenda/
15. [Tracxn] Automata - 2026 Company Profile, Team, Funding, Competitors & Financials | https://tracxn.com/d/companies/automata/__vtzMrTh1JZ-G_YTywreHx0BO6sWPHMZuWkVuv2N7maM